Sequencing Therapies: Optimal Treatment for HR+/HER2– Metastatic Breast Cancer

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	25-27
Number of pages	3
Journal	Clinical Advances in Hematology and Oncology
Volume	22
Issue number	1
State	Published - Jan 2024

ASJC Scopus subject areas

@article{5f22c0763ba44b85b2a84c9b17af5413,

title = "Sequencing Therapies: Optimal Treatment for HR+/HER2– Metastatic Breast Cancer",

author = "Virginia Kaklamani",

year = "2024",

month = jan,

language = "English (US)",

volume = "22",

pages = "25--27",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "1",

}

TY - JOUR

T1 - Sequencing Therapies

T2 - Optimal Treatment for HR+/HER2– Metastatic Breast Cancer

AU - Kaklamani, Virginia

PY - 2024/1

Y1 - 2024/1

UR - http://www.scopus.com/inward/record.url?scp=85183661627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85183661627&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 38294737

AN - SCOPUS:85183661627

SN - 1543-0790

VL - 22

SP - 25

EP - 27

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 1

ER -